Drug Penetration Into Bone After Repeated Oral Administration of Debio 1450 to Patients Undergoing Hip Replacement Surgery
NCT02726438
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
17
Enrollment
INDUSTRY
Sponsor class
Conditions
Bone Diseases, Infectious
Interventions
DRUG:
Debio 1450
Sponsor
Debiopharm International SA